US Patent Issued to CANCER RESEARCH TECHNOLOGY, The Institute of Cancer Research: Royal Cancer Hospital on Dec. 2 for "BCL6 inhibitors" (British Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,285, issued on Dec. 2, was assigned to CANCER RESEARCH TECHNOLOGY Ltd. (London) and The Institute of Cancer Research: Royal Cancer Hospital (London).

"BCL6 inhibitors" was invented by Benjamin Richard Bellenie (London), Kwai Ming Jack Cheung (London), Owen Alexander Davis (London), Swen Hoelder (London), Rosemary Huckvale (London), Gavin Collie (London), Mirco Meniconi (London), Alfie Brennan (London) and Matthew Garth Lloyd (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds of formula I that function as inhibitors of BCL6 (B-cell lymphoma 6) activity:wherein X1, X2, R1, R2, R30, R31 and Ring A are each ...